de Simone G, Devereux R B, Palmieri V, Roman M J, Celentano A, Welty T K, Fabsitz R R, Contaldo F, Howard B V
Division of Cardiology, New York-Presbyterian Hospital, Weill Medical College, Cornell University, 525 East 68th Street, New York, N.Y. 10021, USA.
Nutr Metab Cardiovasc Dis. 2003 Jun;13(3):140-7. doi: 10.1016/s0939-4753(03)80173-4.
To investigate whether insulin-resistance influences echocardiographic markers of preclinical disease, independent of significant confounders.
We examined 1,471 (59 +/- 8 years) non-diabetic individuals (WHO criteria) with available echocardiograms from the Strong Heart Study cohort. Among them, 530 subjects had arterial hypertension (62% on medications), 152 had impaired glucose tolerance (GT) and 460 were normotensive, non-obese with normal GT. Insulin resistance was estimated by the Homeostasis Model Assessment (HOMA). LV mass, systolic function measured at the endocardium and the midwall (also correcting for circumferential wall stress) and arterial compliance (stroke volume/pulse pressure as a percent of predicted from body weight, age and heart rate [delta %SV/PP]) were measured by echocardiography, as prognostically validated markers of preclinical disease. HOMA-index was related positively to body mass index (BMI), waist/hip ratio (WHR), blood pressure, left ventricular (LV) mass, and negatively to arterial compliance (all p < 0.005) in the whole population, as well as in separate normotensive or hypertensive groups. In multiple regression models, relation of HOMA-index with the markers of risk was adjusted for age, sex, WHR, body mass index, presence of hypertension and number of antihypertensive medications. In this analysis, neither LV mass nor indices of systolic function were independently related to HOMA-index. In contrast, HOMA-index maintained a significant negative association with delta %SV/PP, independent of demographics, hypertension, treatment and body fat distribution. Also, HOMA-index maintained an independent relation with LV mass, when WHR and BMI were not included in the regression model.
After accounting for relevant biological covariates, including body mass and fat distribution, insulin-resistance measured by HOMA is not an independent correlate of LV mass and function, but negatively influences arterial compliance.
研究胰岛素抵抗是否独立于显著混杂因素影响临床前期疾病的超声心动图指标。
我们对来自强心脏研究队列的1471名(年龄59±8岁)非糖尿病个体(符合世界卫生组织标准)进行了检查,这些个体均有可用的超声心动图。其中,530名受试者患有动脉高血压(62%正在接受药物治疗),152名葡萄糖耐量受损(IGT),460名血压正常、非肥胖且葡萄糖耐量正常。采用稳态模型评估(HOMA)法估算胰岛素抵抗。通过超声心动图测量左心室质量、心内膜和室壁中层的收缩功能(同时校正圆周壁应力)以及动脉顺应性(每搏量/脉压占根据体重、年龄和心率预测值的百分比[Δ%SV/PP]),这些指标是经预后验证的临床前期疾病标志物。在总体人群以及单独的血压正常或高血压组中,HOMA指数与体重指数(BMI)、腰臀比(WHR)、血压、左心室(LV)质量呈正相关,与动脉顺应性呈负相关(均p<0.005)。在多元回归模型中,对HOMA指数与风险标志物的关系进行了年龄、性别、WHR、体重指数、高血压的存在情况以及抗高血压药物数量的校正。在此分析中,左心室质量和收缩功能指标均与HOMA指数无独立相关性。相比之下,HOMA指数与Δ%SV/PP保持显著负相关,独立于人口统计学、高血压、治疗情况和体脂分布。此外,当回归模型中不包括WHR和BMI时,HOMA指数与左心室质量保持独立关系。
在考虑了包括体重和脂肪分布在内的相关生物学协变量后,通过HOMA测量的胰岛素抵抗并非左心室质量和功能的独立相关因素,但对动脉顺应性有负面影响。